Fig. 10From: Verification of TREX1 as a promising indicator of judging the prognosis of osteosarcomaEffect of different concentrations of cisplatin on the survival rate of CD133+ and CD133− cell subsets in human osteosarcoma MNNG/HOS cells in different time (a:24 h; b:48 h and c:72 h)Back to article page